RTOG 9802: the end of the beginning?
description
Transcript of RTOG 9802: the end of the beginning?
![Page 1: RTOG 9802: the end of the beginning?](https://reader033.fdocuments.us/reader033/viewer/2022061510/5681677d550346895ddc82b4/html5/thumbnails/1.jpg)
RTOG 9802: the end of the beginning?
Presented By Martin Van Den Bent at 2014 ASCO Annual Meeting
![Page 2: RTOG 9802: the end of the beginning?](https://reader033.fdocuments.us/reader033/viewer/2022061510/5681677d550346895ddc82b4/html5/thumbnails/2.jpg)
Low grade glioma
Presented By Martin Van Den Bent at 2014 ASCO Annual Meeting
![Page 3: RTOG 9802: the end of the beginning?](https://reader033.fdocuments.us/reader033/viewer/2022061510/5681677d550346895ddc82b4/html5/thumbnails/3.jpg)
What are the issues?
Presented By Martin Van Den Bent at 2014 ASCO Annual Meeting
![Page 4: RTOG 9802: the end of the beginning?](https://reader033.fdocuments.us/reader033/viewer/2022061510/5681677d550346895ddc82b4/html5/thumbnails/4.jpg)
R9802 SCHEMA
Presented By Martin Van Den Bent at 2014 ASCO Annual Meeting
![Page 5: RTOG 9802: the end of the beginning?](https://reader033.fdocuments.us/reader033/viewer/2022061510/5681677d550346895ddc82b4/html5/thumbnails/5.jpg)
Presented at ASCO 2008, published 2012
Presented By Martin Van Den Bent at 2014 ASCO Annual Meeting
![Page 6: RTOG 9802: the end of the beginning?](https://reader033.fdocuments.us/reader033/viewer/2022061510/5681677d550346895ddc82b4/html5/thumbnails/6.jpg)
What were the issues?
Presented By Martin Van Den Bent at 2014 ASCO Annual Meeting
![Page 7: RTOG 9802: the end of the beginning?](https://reader033.fdocuments.us/reader033/viewer/2022061510/5681677d550346895ddc82b4/html5/thumbnails/7.jpg)
ASCO 2014: Overall Survival
Presented By Martin Van Den Bent at 2014 ASCO Annual Meeting
![Page 8: RTOG 9802: the end of the beginning?](https://reader033.fdocuments.us/reader033/viewer/2022061510/5681677d550346895ddc82b4/html5/thumbnails/8.jpg)
Conclusions
Presented By Martin Van Den Bent at 2014 ASCO Annual Meeting
![Page 9: RTOG 9802: the end of the beginning?](https://reader033.fdocuments.us/reader033/viewer/2022061510/5681677d550346895ddc82b4/html5/thumbnails/9.jpg)
Three trials on adjuvant PCV chemotherapy: the anaplastic OD and LGG trials
Presented By Martin Van Den Bent at 2014 ASCO Annual Meeting
![Page 10: RTOG 9802: the end of the beginning?](https://reader033.fdocuments.us/reader033/viewer/2022061510/5681677d550346895ddc82b4/html5/thumbnails/10.jpg)
Delayed benefit of chemotherapy
Presented By Martin Van Den Bent at 2014 ASCO Annual Meeting
![Page 11: RTOG 9802: the end of the beginning?](https://reader033.fdocuments.us/reader033/viewer/2022061510/5681677d550346895ddc82b4/html5/thumbnails/11.jpg)
New WHO grading scheme?
Presented By Martin Van Den Bent at 2014 ASCO Annual Meeting
![Page 12: RTOG 9802: the end of the beginning?](https://reader033.fdocuments.us/reader033/viewer/2022061510/5681677d550346895ddc82b4/html5/thumbnails/12.jpg)
What are the unanswered questions?
Presented By Martin Van Den Bent at 2014 ASCO Annual Meeting
![Page 13: RTOG 9802: the end of the beginning?](https://reader033.fdocuments.us/reader033/viewer/2022061510/5681677d550346895ddc82b4/html5/thumbnails/13.jpg)
What are the unanswered questions?
Presented By Martin Van Den Bent at 2014 ASCO Annual Meeting
![Page 14: RTOG 9802: the end of the beginning?](https://reader033.fdocuments.us/reader033/viewer/2022061510/5681677d550346895ddc82b4/html5/thumbnails/14.jpg)
What are the unanswered questions?
Presented By Martin Van Den Bent at 2014 ASCO Annual Meeting
![Page 15: RTOG 9802: the end of the beginning?](https://reader033.fdocuments.us/reader033/viewer/2022061510/5681677d550346895ddc82b4/html5/thumbnails/15.jpg)
EORTC 22033 on RT vs TMZ in low grade glioma: PFS in relation to 1p status
Presented By Martin Van Den Bent at 2014 ASCO Annual Meeting
![Page 16: RTOG 9802: the end of the beginning?](https://reader033.fdocuments.us/reader033/viewer/2022061510/5681677d550346895ddc82b4/html5/thumbnails/16.jpg)
Slide 16
Presented By Martin Van Den Bent at 2014 ASCO Annual Meeting
![Page 17: RTOG 9802: the end of the beginning?](https://reader033.fdocuments.us/reader033/viewer/2022061510/5681677d550346895ddc82b4/html5/thumbnails/17.jpg)
2014: the role of chemotherapy established in all diffuse glioma
Presented By Martin Van Den Bent at 2014 ASCO Annual Meeting
![Page 18: RTOG 9802: the end of the beginning?](https://reader033.fdocuments.us/reader033/viewer/2022061510/5681677d550346895ddc82b4/html5/thumbnails/18.jpg)
Now what?
Presented By Martin Van Den Bent at 2014 ASCO Annual Meeting
![Page 19: RTOG 9802: the end of the beginning?](https://reader033.fdocuments.us/reader033/viewer/2022061510/5681677d550346895ddc82b4/html5/thumbnails/19.jpg)
Slide 19
Presented By Martin Van Den Bent at 2014 ASCO Annual Meeting